Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  H. DeLuca,et al.  Effects of increasing doses of 1α‐hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women , 1994 .

[3]  M. Uskoković,et al.  Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3. Lack of modulation by 9-cis-retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives. , 1994, The Journal of biological chemistry.

[4]  H. DeLuca,et al.  Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. , 1993, Molecular endocrinology.

[5]  M. Galligan,et al.  Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene , 1993, Molecular and cellular biology.

[6]  H. DeLuca,et al.  Phosphorylation is involved in transcriptional activation by the 1,25-dihydroxyvitamin D3 receptor. , 1993, Biochimica et biophysica acta.

[7]  M. Noshiro,et al.  Parathyroid hormone inhibits 25-hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1 alpha,25-dihydroxyvitamin D3 in rat kidney but not in intestine. , 1992, The Journal of biological chemistry.

[8]  J. Eisman,et al.  Nonhypercalcemic 1,25‐(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO‐2) , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  B. Sacktor,et al.  Osteocalcin secretion by the human osteosarcoma cell line MG‐63 , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  P. Mäenpää,et al.  Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. , 1990, Biochimica et biophysica acta.

[11]  J. Shine,et al.  1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. , 1989, Science.

[12]  H. DeLuca,et al.  An immunoradiometric assay for 1,25-dihydroxyvitamin D3 receptor. , 1989, Analytical biochemistry.

[13]  R. Horst,et al.  Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer. , 1989, Archives of biochemistry and biophysics.

[14]  D. Rowe,et al.  1,25-Dihydroxyvitamin D3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. , 1989, Endocrinology.

[15]  G. Rodan,et al.  Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3. , 1988, Biochemistry.

[16]  P. Price,et al.  1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. , 1988, The Journal of biological chemistry.

[17]  W. Butler,et al.  1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. , 1987, Collagen and related research.

[18]  G. Rodan,et al.  The effect of 1,25‐dihydroxyvitamin D3 on the cytoskeleton of rat calvaria and rat osteosarcoma (ROS 17/2.8) osteoblastic cells , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  V. Rosen,et al.  Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. , 1986, The EMBO journal.

[20]  H. DeLuca,et al.  Synthesis of 1α,25-dihydroxyvitamin D2, its 24 epimer and related isomers, and their binding affinity for the 1,25-dihydroxyvitamin D3 receptor , 1985 .

[21]  H. Sussman,et al.  1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. , 1983, The Journal of biological chemistry.

[22]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[23]  P. Price,et al.  1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. , 1980, The Journal of biological chemistry.

[24]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[25]  M. Haussler,et al.  1,25-Dihydroxyvitamin D3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. , 1980, The Journal of biological chemistry.

[26]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[27]  H. DeLuca,et al.  Bone Resorbing Activity of Vitamin D Metabolites and Congeners in Vitro: Influence of Hydroxy1 Substituents in the A Ring , 1975 .

[28]  H. DeLuca,et al.  Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. , 1974, Endocrinology.

[29]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture , 1972, Science.

[30]  H. DeLuca,et al.  Chapter 18. Vitamin D: Metabolism and Mechanism of Action , 1984 .

[31]  Jeffrey H. Miller.  Experiments in molecular genetics , 1972 .